CAV2 and concussion: In the present study, we focus on TRPV4 and its inhibitors while using memantine/NMDAR and gabapentin/Cav2 channels as comparison, since the two TRPV4 blockers have the most striking protective effects in our studies and have not yet been investigated in mTBI.